Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 21 Etoposide 20 Carboplatin 20 Topotecan 13 pembrolizumab 12 durvalumab 11 Paclitaxel 10 Irinotecan 9 Nivolumab 7 Gemcitabine 7 tremelimumab 6 atezolizumab 6 Radiotherapy 6 Docetaxel 6 Pemetrexed 5 Ipilimumab 5 Cyclophosphamide 5 rovalpituzumab tesirine 4 budigalimab 4 Specimen Handling 4 Injections 4 Doxorubicin 4 Bortezomib 4 130-nm albumin-bound paclitaxel 4 venetoclax 3 talazoparib 3 olaparib 3 fludarabine 3 etoposide phosphate 3 Platinum 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Small Cell Lung Carcinoma × Radioimmunotherapy × Clear all

NCT03467360 2026-01-20

ICAR

Centre Antoine Lacassagne

Phase 1 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡